CTX-712 |
| رقم الكتالوجGC65023 |
CTX-712 هو مثبط قوي للكيناز الذي يشبه cdc2 (CLK)يثبط CTX-712 نشاط إنزيم CLK ، وبالتالي يمنع بقاء السرطان ونمو الخلايا السرطانيةCTX-712 لديه القدرة على البحث عن مرض السرطان (مستخرج من براءة الاختراع JPWO2017188374A1 ، المركب 286)
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 2144751-78-8
Sample solution is provided at 25 µL, 10mM.
;)
,-1-7$$$37316672.jpg');)
;)
;)
$$$36806353.jpg');)
;33(7)%EF%BC%9A546-561$$$37156877.jpg');)
;)
;)
;)
%201124-1138.$$$35908550.jpg');)
%20766-780.$$$37100057.jpg');)
%20418-432.$$$36893736.jpg');)
%EF%BC%9A-240-255.$$$35108512.jpg');)
533-545$$$36543525.jpg');)
%201-13.$$$36600053.jpg');)
;)
CTX-712 is a potent inhibitor of cdc2-like kinase (CLK). CTX-712 inhibits CLK kinase activity, and thus inhibits cancer survival and cancer cell growth. CTX-712 has the potential for the research of cancer disease (extracted from patent JPWO2017188374A1, compound 286)[1].
[1]. Fused heterocyclic compounds. Patent JPWO2017188374A1.
Average Rating: 5 (Based on Reviews and 30 reference(s) in Google Scholar.)
GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *